Carcinoma, Ductal, Breast
"Carcinoma, Ductal, Breast" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
Descriptor ID |
D018270
|
MeSH Number(s) |
C04.557.470.200.025.232.500 C04.557.470.615.132.500 C04.588.180.390 C17.800.090.500.390
|
Concept/Terms |
Carcinoma, Ductal, Breast- Carcinoma, Ductal, Breast
- Carcinoma, Invasive Ductal, Breast
- Invasive Ductal Carcinoma, Breast
- Carcinoma, Infiltrating Duct
- Carcinomas, Infiltrating Duct
Carcinoma, Mammary Ductal- Carcinoma, Mammary Ductal
- Carcinomas, Mammary Ductal
- Mammary Ductal Carcinomas
- Mammary Ductal Carcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Ductal, Breast".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Ductal [C04.557.470.200.025.232]
- Carcinoma, Ductal, Breast [C04.557.470.200.025.232.500]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Carcinoma, Ductal [C04.557.470.615.132]
- Carcinoma, Ductal, Breast [C04.557.470.615.132.500]
- Neoplasms by Site [C04.588]
- Breast Neoplasms [C04.588.180]
- Carcinoma, Ductal, Breast [C04.588.180.390]
- Skin and Connective Tissue Diseases [C17]
- Skin Diseases [C17.800]
- Breast Diseases [C17.800.090]
- Breast Neoplasms [C17.800.090.500]
- Carcinoma, Ductal, Breast [C17.800.090.500.390]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Ductal, Breast".
This graph shows the total number of publications written about "Carcinoma, Ductal, Breast" by people in this website by year, and whether "Carcinoma, Ductal, Breast" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2006 | 2 | 0 | 2 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2011 | 3 | 0 | 3 |
2012 | 2 | 0 | 2 |
2013 | 3 | 0 | 3 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Ductal, Breast" by people in Profiles.
-
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis. J Natl Cancer Inst. 2019 04 01; 111(4):380-387.
-
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers. BMC Med Genomics. 2018 Sep 20; 11(1):80.
-
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer. Clin Breast Cancer. 2017 07; 17(4):279-285.
-
May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer? Gynecol Endocrinol. 2016; 32(1):58-60.
-
CNS metastases in breast cancer patients: prognostic implications of tumor subtype. Med Oncol. 2015 Jan; 32(1):400.
-
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013 Jun; 14(7):609-18.
-
Relationship between circulating tumor cells and peripheral T-cells in patients with primary breast cancer. Anticancer Res. 2013 May; 33(5):2233-8.
-
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse. Breast Cancer Res Treat. 2013 Apr; 138(2):509-17.
-
CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary. J Cancer Res Clin Oncol. 2013 Apr; 139(4):551-6.
-
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res. 2012 Jan 20; 14(1):R15.